Importantly, SLC30A8 LoF did not impact BMI (ESM Table 6), and may represent an alternative mechanism for type 2 diabetes treatment and prevention that is independent of currently available weight loss therapies. Here, SLC30A8 is linked to type 2 diabetes mellitus.